Alerts will be sent to your verified email
Verify Email
UNICK
|
Unick Fix-A-Form
|
Ishita Drugs & Inds.
|
Medicamen Organics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.1 % | 8.38 % | 13.81 % |
|
5yr average Equity Multiplier
|
2.38 | 1.27 | 2.71 |
|
5yr Average Asset Turnover Ratio
|
0.87 | 1.23 | 0.66 |
|
5yr Avg Net Profit Margin
|
3.9 % | 5.43 % | 8.45 % |
|
Price to Book
|
0.7 | 2.14 | 0.0 |
|
P/E
|
11.61 | 26.94 | 6.32 |
|
5yr Avg Cash Conversion Cycle
|
35.77 Days | 74.52 Days | -17.75 Days |
|
Inventory Days
|
63.15 Days | 35.08 Days | 81.12 Days |
|
Days Receivable
|
70.74 Days | 31.6 Days | 203.36 Days |
|
Days Payable
|
123.98 Days | 42.7 Days | 289.0 Days |
|
5yr Average Interest Coverage Ratio
|
2.43 | 24.46 | 7.35 |
|
5yr Avg ROCE
|
12.53 % | 11.48 % | 22.44 % |
|
5yr Avg Operating Profit Margin
|
14.0 % | 6.66 % | 14.84 % |
|
5 yr average Debt to Equity
|
0.78 | 0.09 | 0.85 |
|
5yr CAGR Net Profit
|
2.3 % | 0.95 % | 33.09 % |
|
5yr Average Return on Assets
|
3.39 % | 6.68 % | 5.55 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.57 % | 50.04 % | 59.73 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
35.93 % | 0.66 % | 0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Unick Fix-A-Form
|
Ishita Drugs & Inds.
|
Medicamen Organics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|